AdaptHealth Corp. (AHCO) director Dale B. Wolf reports 40,000-share stock purchase

Rhea-AI Filing Summary

AdaptHealth Corp. director Dale B. Wolf reported open-market purchases of common stock on two consecutive days. On August 6, 2026, he purchased 20,000 shares at $6.37 per share, bringing his directly held position to 143,234 shares. On August 7, 2026, an additional 20,000 shares were purchased at a weighted average price of $5.86 per share, in multiple trades between $5.83 and $5.885, for the Dale B. Wolf Generation Skipping Trust, which now holds 34,000 shares with Wolf as investment manager.

Insider Trade Summary

Net Buyer: 40,000 shares

Net Buy 2 txns

Insider WOLF DALE B

Role Director

Bought 40,000 shs ($245K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2	20,000	$5.86	$117K
Purchase	Common Stock	20,000	$6.37	$127K

Holdings After Transaction: Common Stock — 143,234 shares (Direct); Common Stock — 34,000 shares (Indirect, By Trust)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
2. F2. Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Key Figures

Direct purchase shares: 20,000 shares Trust purchase shares: 20,000 shares Direct holdings after transaction: 143,234 shares +3 more

6 metrics

Direct purchase shares 20,000 shares Common Stock purchased on August 6, 2026 at $6.3700 per share

Trust purchase shares 20,000 shares Common Stock purchased on August 7, 2026 at $5.86 weighted average

Direct holdings after transaction 143,234 shares Total common shares directly held by Dale B. Wolf after August 6, 2026 trade

Indirect trust holdings 34,000 shares Common shares held by the Dale B. Wolf Generation Skipping Trust after August 7, 2026 trades

Weighted average price range $5.83–$5.885 per share Price range for August 7, 2026 trades comprising the $5.86 weighted average

Direct trade price $6.3700 per share Per-share price for August 6, 2026 direct purchase of 20,000 shares

Key Terms

weighted average price, Generation Skipping Trust, investment manager

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Generation Skipping Trust financial

"Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST")."

investment manager financial

"The reporting person is the investment manager of the GST."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/10/2026 - 08:03 PM Accepted by SEC EDGAR 08/10/2026 - 08:02 PM Learn about SEC filing dates

FAQ

What insider buying did AdaptHealth Corp. (AHCO) disclose for Dale B. Wolf?

AdaptHealth Corp. disclosed that director Dale B. Wolf was involved in purchases totaling 40,000 shares of common stock. These included 20,000 shares bought directly and 20,000 shares bought for a trust he manages.

At what prices did Dale B. Wolf buy AHCO shares in the recent transactions?

Dale B. Wolf bought 20,000 AHCO shares at $6.37 per share on August 6, 2026. A related trust bought another 20,000 shares at a weighted average price of $5.86, in trades between $5.83 and $5.885.

How many AdaptHealth (AHCO) shares does Dale B. Wolf hold after these purchases?

After the reported purchases, Dale B. Wolf directly holds 143,234 shares of AdaptHealth common stock. A Generation Skipping Trust for which he is investment manager holds an additional 34,000 shares indirectly attributed to him.

Were the recent AHCO insider purchases made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked, so these transactions were not reported as occurring under a pre-arranged 10b5-1 trading plan, based on the document’s plan status indicator.

What role does the Dale B. Wolf Generation Skipping Trust play in AHCO share ownership?

A Generation Skipping Trust associated with Dale B. Wolf holds 34,000 AHCO shares. The filing states Wolf is the investment manager of this trust, and these shares are reported as indirectly owned through the trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2026		P		20,000	A	$6.37	143,234	D
Common Stock	08/07/2026		P		20,000	A	$5.86(1)	34,000	I	By Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

2. Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Dale Wolf	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)